Protein recognition using synthetic surface-targeted agents

Molecular Diversity

Volumn 8, Issue 2, 2004, Pages 89-100

  Jain, Rishi ^a   Ernst, Justin T ^a   Kutzki, Olaf ^a   Hyung, Soon Park ^a   Hamilton, Andrew D ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; CYTOCHROME C; CYTOCHROME C PEROXIDASE; PLATELET DERIVED GROWTH FACTOR;

MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW;

AMINO ACID SEQUENCE; BIOCHEMISTRY; CHYMOTRYPSIN; CYTOCHROME-C PEROXIDASE; CYTOCHROMES C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; ORGANIC CHEMICALS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN CONFORMATION; PROTEINS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 3542995065     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MODI.0000025652.55320.16     Document Type: Review

References (73)

1. Weber, P. C., Ohlendorf, D. H., Wendoloski, J. J. and Salemme, F. R., Structural origins of high-affinity biotin binding to streptavidin, Science, 243 (1989) 85.
2. Buckle, A. M., Schreiber, G. and Fersht, A. R., Protein-protein interaction - Crystal structure analysis of a barnase-barstar complex at 2.0-angstrom resolution, Biochemistry, 3 (1994) 8878-8889.
3. Blokzul, W. and Engberts, J. B. F. N., Hydrophobic effects-opinions and facts, Angew. Chem. Int. Ed. Engl., 32 (1993) 1545-1579.
4. Southall, N. T., Dill, K. A. and Haymet A. D. J., A view of the hydrophobic effect, J. Phys. Chem. B, 106 (2002) 521-533.
5. Dervan, P. B., Molecular recognition of DNA by small molecules, Bioorg. Med. Chem., 9 (2001) 2215-2235.
6. Fan, E., Zhang, Z., Minke, W. E., Hou, Z., Verlinde, C. L. M. J. and Hol, W. G. J., High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design, J. Am. Chem. Soc., 122 (2000) 2663-2664.
7. Mammen, M., Choi, S. K. and Whitesides, G. M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors, Angew. Chemie. Int. Ed., 37 (1998) 2754-2794.
8. (a) Cochran, A. G., Protein-protein interfaces: Mimics and inhibitors, Curr. Opin. Chem. Biol., 5 (2001) 654-659.
9. (b) Chmielewski, J., Zutshi, R. and Brickner, M., Inhibiting the assembly of protein-protein interfaces, Curr. Opin. Chem. Biol., 2 (1998) 62-66.
10. Toogood, P. L., Inhibition of protein-protein association by small molecules: Approaches and progress, J. Med. Chem., 45 (2002) 1543-1558.
11. (a) Chothia, C. and Janin, J., Principles of protein-protein recognition, Nature, 256 (1975) 705-708.
12. (b) Jones, S. and Thornton, J. M., Principles of protein-protein interactions, Proc. Natl. Acad. Sci. USA, 93 (1996) 13-20.
13. (c) Le Conte, L., Chothia, C. and Janin, J., Atomic structure of protein-protein recognition sites, J. Mol. Biol., 285 (1999) 2177-2198.
14. Stites, W. E., Protein-protein interactions: Interface structure, binding thermodynamics, and mutational analysis, Chem. Rev., 97 (1997) 1233-1250.
15. (a) Bogan, A. A. and Thorn, K. S., Anatomy of hot spots in protein interfaces, J. Mol. Biol., 280 (1998) 1-9.
16. (b) Clackson, T. and Wells, J. A., A hot-spot of binding-energy in a hormone-receptor interface, Science, 267 (1995) 383-386.
17. (a) Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M. and Wells, J. A., Site-directed ligand discovery, Proc. Natl. Acad. Sci. USA, 97 (2000) 9367-9372.
18. (b) Hajduk, P. J., Bures, M., Praestgaard, J. and Fesik, S. W., Privileged molecules for protein binding identified from NMR-based screening, J. Med. Chem., 43 (2000) 3443-3447.
19. (c) DeLano, W. L., Unraveling hot spots in binding interfaces: Progress and challenges, Curr. Opin. Struct. Biol., 12 (2002) 14-20.
20. (a) Ojwong, J. O. and Rando R. F. et al., T30177 an oligonucleotide stabilized by a intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type I, Anti Microb. Agents Chemother., 39 (1995) 2426-2435.
21. (b) Capila, I. and Linhardt, R. J., Heparin - Protein interactions, Angew. Chem. Int. Ed., 41 (2002) 391-412.
22. Petitou, M., Herault, L. P., Bernat, A., Driguez, P. A., Duchaussoy, P., Lormeau, J. C. and Herbert, J. M., Synthesis of thrombin-inhibiting heparin mimetics without side effects, Nature, 398 (1999) 417-422.
23. Peczuh, M. W. and Hamilton, A. D., Peptide and protein recognition by designed molecules, Chem. Rev., 100 (2000) 2479-2493.
24. Ding, W. and Ellestatad, G. A. et al., Novel and specific respiratory syncytial virus inhibitors that target virus fusion, J. Med. Chem., 41 (1998) 2671-2675.
25. Halliday, S. M., Lackman-Smith, C, Bader, J. P., Rice, W. G., Clanton, D. J., Zalkow, L. H., Buckheit Jr., R. W., Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene, Antiviral Res., 33 (1996) 41-53.
26. Dezube, B. J. and Crumpacker, C. S., et al., A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: A phase I study, J. Infect. Dis., 182 (2000) 607-610.
27. Manetti, F., Cappello, V., Botta, M., Corelli, F., Mongelli, N., Biasoli, G., Lombardi-Borgia, A. and Ciomei, M., Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor, Bioorg. Med. Chem., 6 (1998) 947-958.
28. Zamai, M., Hariharan, C., Pines, D., Safran, M., Yayon, A., Caiolfa, V. R., Cohen-Luria, R., Pines, E. and Parola, A. H., Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl- bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )-bis-(1,3-napthalene disulfonate) II. Removal of polar interactions affects protein folding, Biophys. J., 82 (2002) 2652-2664.
29. Aviezer, D., Cotton, S., Magda, D., Segev, A., Khasalev, N., Galili, N., Gross, Z. and Yayon, A., Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis, Cancer Res., 60 (2000) 2973-2980.
30. Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., Boger, D. L. and Vogt, P. K., Proc. Natl. Acad. Sci., 99 (2002) 3830-3835.
31. Leung, D. K., Yang, Z. and Breslow, R., Selective disruption of protein aggregation by cyclodextrin dimers, Proc. Natl. Acad. Sci. USA, 97 (2000) 5050-5053.
32. Abul Fazal, M., Roy, B. C., Sun, S., Mallik, S. and Rodgers K. R., Surface recognition of a protein using designed transition metal complexes, J. Am. Chem. Soc., 123 (2001) 6283-6290.
33. Park, H. S., Lin, Q., Hamilton, A. D., Protein surface recognition by synthetic receptors: A route to novel submicromolar inhibitors for alpha-chymotrypsin, J. Am. Chem. Soc., 121 (1999) 8-13.
34. Fischer, N. O., McIntosh, C. N., Simard, J. M. and Rotello, V. M., Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors, Proc. Natl. Acad. Sci USA, 99 (2002) 5018-5023.
35. (a) Li, A. P., Screening for human ADME/Tox drug properties in drug discovery, Drug. Discov. Today, 6 (2001) 357-366.
36. (b) Walters, W. P. and Murcko, M. A., Prediction of 'drug-likeness', Adv. Drug Deliver. Rev., 54 (2002) 255-271.
37. Lipinski, C. A., Lombardo, F., Dominy, B. W. and Feeney, P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug. Deliver. Rev., 23 (1997) 3-25.
38. Kabsch, W. and Sander, C., Dictionary of protein secondary structure - Pattern-recognition of hydrogen-bonded and geometrical features, Biopolymers, 22 (1983) 2577-2637.
39. Merutka, G. and Stellwagen, F., Effect of amino acid ion pairs on peptide helicity, Biochemistry, 30 (1991) 1591-1594.
40. (a) Ghadiri, M. R. and Choi, C., Secondary structure nucleation in peptides. Transition metal ion stabilized α-helices, J. Am. Chem. Soc., 112 (1990) 1630-1632.
41. (b) Ruan, F., Chen, Y. and Hopkins, P. B., Metal ion enhanced helicity in synthetic peptides containing unnatural, metal-ligating residues, J. Am. Chem. Soc., 112 (1990) 9403-9404.
42. Albert, J. A. and Hamilton, A. D., Stabilization of helical domains in short peptides using hydrophobic interactions, Biochemistry, 34 (1995) 984-990.
43. Jackson, D. Y., King, D. S., Chmielewski, J., Singh, S. and Shultz, P. G., General approach to the synthesis of short α-helical peptides, J. Am. Chem. Soc., 113 (1991) 9391-9392.
44. Osapay, G. and Taylor, J. W., Multicyclic polypeptide model compounds. 2. Synthesis and conformational properties of a highly α-helical uncosapeptide constrained by three side-chain to side-chain lactam bridges, J. Am. Chem. Soc., 114 (1992) 6966-6973.
45. Yu, C. and Taylor, J. W., Synthesis and study of peptides with semirigid i and i+7 side-chain bridges designed for α-helix stabilization, Bioorg. Med. Chem., 7 (1999) 161-175.
46. Cabezas, E. and Satterthwait, A. C., The hydrogen bond mimic approach: Solid-phase synthesis of a peptide stabilized as an α-helix with a hydrazone link, J. Am. Chem. Soc., 121 (1999) 3862-3875.
47. (a) Schafmeister, C. E., Po, J. and Verdine, G. L., An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides, J. Am. Chem. Soc., 122 (2000) 5891-5892,
48. (b) Blackwell, H. E. and Grubbs, R. H., Highly efficient synthesis of covalently cross-linked peptide helices by ring-closing metathesis, Angew. Chem. Int. Ed., 37 (1998) 3281-3284.
49. (a) Chin, J. W. and Schepartz, A., Design and evolution of a miniature Bcl-2 binding protein, Angew. Chem. Int. Ed., 40 (2001) 3806-3809.
50. (b) Zondlo, N. J. and Schepartz, A., Highly specific DNA recognition by a designed miniature protein, J. Am. Chem. Soc., 121 (1999) 6938-6939.
51. (c) Struthers, M. D., Cheng, R. P. and Imperiali, B., Economy in protein design: Evolution of a metal-independent ββα motif based on the zinc finger domains, J. Am. Chem. Soc., 118 (1996) 3073-3081.
52. (a) Stigers, K. D., Soth, M. J. and Nowick, J. S., Designed molecules that fold to mimic protein secondary structures, Curr. Opin. Chem. Biol., 3 (1999) 714-723.
53. (b) Gellman, S. H., Foldamers: A manifesto, Acc. Chem. Res., 31 (1998) 173-180.
54. (a) Austin, R. E., Maplestone, R. A., Sefler, A. M., Liu, K., Hruzwicz, W. N., Liu, C. W., Cho, H. S., Wemmer, D. E. and Bartlett, P. A., A template for stabilization of a peptide α-helix: Synthesis and evaluation of conformational effects by circular dichroism and NMR, J. Am. Chem. Soc., 119 (1997) 6461-6472.
55. (b) Kemp, D. S., Allen, T. J., Oslick, S. A. and Boyd, J. G., The structure and energetics of helix formation by short templated peptides in aqueous solution. 2. Characterization of the helical structure of Ac-Hell-Ala6-OH, J. Am. Chem. Soc., 118 (1996) 4240-4248.
56. Nesloney, C. L. and Kelly, J. W., For an example of 2,3′- disubstituted biphenyls as constrained turn mimics see, A 2,3′-substituted biphenyl based amino acid facilitates the formation of monomeric β-hairpin like structure in aqueous solution at elevated temperature, J. Am. Chem. Soc., 118 (1996) 5836-5845.
57. Jacoby, E., Biphenyls as potential mimetics of protein α-helix, Bioorg. Med. Chem. Lett, 12 (2002) 891-893.
58. Orner, B. P., Ernst, J. T. and Hamilton, A. D., Towards proteomimetics: Terphenyl derivatives as structural and functional mimics of extended regions of an α-helix, J. Am. Chem. Soc., 123 (2001) 5382-5383.
59. Ernst, J. T., Debnath, A. K., Jiang, S., Lu, H. and Hamilton, A. D., Design of a protein surface antagonist based on α-helix mimicry: Inhibition of gp41 assembly and viral fusion, Angew. Chem. Int. Ed., 41 (2002) 278-281.
60. Kutzki, O., Park, H. S., Ernst, J. T., Orner, B. P., Yin, H. and Hamilton, A. D., Development of a potent Bcl-xL antagonist based on α-helix mimicry, J. Am. Chem. Soc., 124 (2002) 11832-11833.
61. Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlin, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., Thompson, C. B. and Fesik, S. W., Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis, Science, 275 (1997) 983-986.
62. Larson, T. A., Olson, A. J. and Goodsell, D. S., Morphology of protein-protein interfaces, Chem. Biol., 6 (1998) 421-427.
63. Odani, S., Komori, and Gejyo, F., Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR), Amyloid, 2 (1999) 77-88.
64. Scheidig, A., Hynes, T., Pelletier, L. A., Wells, J. A. and Kossiakoff, A. A., Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimers amyloid β-protein precursor and basic pancreatic trypsin inhibitor: Engineering of inhibitors with altered specificities, Prot. Sci., 6 (1997) 1806-1824.
65. (a) Lin, Q., Park, H. S., Hamuro, Y., Lee, C. S. and Hamilton, A. D., Protein surface recognition by synthetic agents: Design and structural requirements of a family of artificial receptors that bind to cytochrome c, Biopolymers, 47 (1998) 285-298.
66. (b) Jain, R. and Hamilton, A. D., Protein surface recognition by synthetic receptors based on a tetraphenylporphyrin scaffold, Organic Lett., (2000) 1721-1723.
67. Wei, Y., McLendon, G. L., Hamilton, A. D., Case, M. A., Purring, C. B., Lin, Q., Park, H. S., Lee, C. S. and Yu, L., Disruption of protein-protein interactions: Design of a synthetic receptor that blocks the binding of cytochrome c to cytochrome c peroxidase, J. Chem. Soc. Chem. Commun., (2001) 1580-1581.
68. Lin, Q. and Hamilton, A. D., Design and synthesis of multiple-loop receptors based on a Calix[4]arene scaffold for protein surface recognition, Comptes Rendues (in press).
69. Park, H. S., Lin, Q. and Hamilton, A. D., Protein surface recognition by synthetic receptors: A route to novel sub-micromolar inhibitors for chymotrypsin, J. Am. Chem. Soc., 121 (1999) 8-13.
70. Park, H. S., Lin, Q. and Hamilton, A. D., Modulation of protein-protein interactions by synthetic receptors: Design of a family of molecules that inhibit serine protease-proteinaceous inhibitor interaction, Proc. Natl. Acad. Sci. USA, 99 (2002) 5105-5109.
71. Oefner, C., Arcy, A. D., Winkler, F. K., Eggimann, B. and Hosang, M., Crystal structure of human platelet derived growth factor, EMBO J., 11 (1992) 3921-3926.
72. Sebti, S. M. and Hamilton, A. D., Design of growth factor antagonists with antiangiogenic and antitumor properties Oncogene, 19 (2000) 6566-6573.
73. Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D. and Sebti, S. M., Design of GFB-111 a platelet-derived growth factor binding molecule with anti-angiogenic and anti-cancer activity against human tumors in mice, Nature Biotechnol., 18(2000) 1065-1070.